RANI - Rani Therapeutics GAAP EPS of -$0.37 beats by $0.04 August, 11 2023 04:23 PM Rani Therapeutics Holdings Inc. 2023-08-11 16:23:30 ET Rani Therapeutics press release ( NASDAQ: RANI ): Q2 GAAP EPS of -$0.37 beats by $0.04 . Cash, cash equivalents and marketable securities as of June 30, 2023, totaled $74.6 million. For further details see: Rani Therapeutics GAAP EPS of -$0.37 beats by $0.04